相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacogenetics of opioid analgesics in dogs
K. Kongara
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2018)
Clopidogrel Pharmacogenetics: Beyond Candidate Genes and Genome-Wide Association Studies
J. P. Lewis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
ABCG2/BCRP: Specific and Nonspecific Modulators
Diana Pena-Solorzano et al.
MEDICINAL RESEARCH REVIEWS (2017)
Validation of a method for quantitation of the clopidogrel active metabolite, clopidogrel, clopidogrel carboxylic acid, and 2-oxo-clopidogrel in feline plasma
Janne G. Lyngby et al.
JOURNAL OF VETERINARY CARDIOLOGY (2017)
ABC transporters as mediators of drug resistance and contributors to cancer cell biology
Jamie I. Fletcher et al.
DRUG RESISTANCE UPDATES (2016)
The Effect of the Canine ABCB1-1 Mutation on Sedation after Intravenous Administration of Acepromazine
D. Deshpande et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2016)
CYP450 genotype and pharmacogenetic association studies: a critical appraisal
Rashmi R. Shah et al.
PHARMACOGENOMICS (2016)
Influence of a low dosage of clopidogrel on platelet function in cats as measured by the platelet function analyser PFA-100 and the multiplate analyser
M. Teuber et al.
RESEARCH IN VETERINARY SCIENCE (2016)
SLC transporters: structure, function, and drug discovery
Claire Colas et al.
MEDCHEMCOMM (2016)
The ABCG2 Efflux Transporter in the Mammary Gland Mediates Veterinary Drug Secretion across the Blood-Milk Barrier into Milk of Dairy Cows
Hanna Mahnke et al.
DRUG METABOLISM AND DISPOSITION (2016)
Tramadol Metabolism to O-Desmethyl Tramadol (M1) and N-Desmethyl Tramadol (M2) by Dog Liver Microsomes: Species Comparison and Identification of Responsible Canine Cytochrome P450s
Tania E. Perez et al.
DRUG METABOLISM AND DISPOSITION (2016)
Addressing phenoconversion: the Achilles' heel of personalized medicine
Rashmi R. Shah et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Short communication: The gain-of-function Y581S polymorphism of the ABCG2 transporter increases secretion into milk of danofloxacin at the therapeutic dose for mastitis treatment
J. A. Otero et al.
JOURNAL OF DAIRY SCIENCE (2015)
Identification of a nonsense mutation in feline ABCB1
K. L. Mealey et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2015)
SNP genetic polymorphisms of MDR-1, CYP1A2 and CYPB11 genes in four canine breeds upon toxicological evaluation
Rosa Gagliardi et al.
JOURNAL OF VETERINARY SCIENCE (2015)
Epigenomes as therapeutic targets
Christopher A. Hamm et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Secondary prevention of cardiogenic arterial thromboembolism in the cat: the double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT)
Daniel F. Hogan et al.
JOURNAL OF VETERINARY CARDIOLOGY (2015)
What do drug transporters really do?
Sanjay K. Nigam
NATURE REVIEWS DRUG DISCOVERY (2015)
Inflammation-Induced Phenoconversion of Polymorphic Drug Metabolizing Enzymes: Hypothesis with Implications for Personalized Medicine
Rashmi R. Shah et al.
DRUG METABOLISM AND DISPOSITION (2015)
Epigenetic Changes in Gene Expression for Drug-Metabolizing Enzymes and Transporters
In-Wha Kim et al.
PHARMACOTHERAPY (2014)
Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog
Elisabeth C. Jeunesse et al.
BMC VETERINARY RESEARCH (2013)
Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics
Marilyn N. Martinez et al.
DRUG METABOLISM REVIEWS (2013)
Determination of functional ABCG2 activity and assessment of drug-ABCG2 interactions in dairy animals using a novel MDCKII in vitro model
Louise Wassermann et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Expression and subcellular localization of efflux transporter ABCG2/BCRP in important tissue barriers of lactating dairy cows, sheep and goats
S. Lindner et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2013)
Adverse Drug Reactions in Veterinary Patients Associated with Drug Transporters
Katrina L. Mealey
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2013)
Canine Cytochrome P-450 Pharmacogenetics
Michael H. Court
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2013)
Feline Drug Metabolism and Disposition Pharmacokinetic Evidence for Species Differences and Molecular Mechanisms
Michael H. Court
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2013)
Effects of triclabendazole on secretion of danofloxacin and moxidectin into the milk of sheep: Role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporter
Borja Barrera et al.
VETERINARY JOURNAL (2013)
Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: Effect on plasma and milk levels of danofloxacin in sheep
Miriam Perez et al.
VETERINARY JOURNAL (2013)
The Bovine ATP-Binding Cassette Transporter ABCG2 Tyr581Ser Single-Nucleotide Polymorphism Increases Milk Secretion of the Fluoroquinolone Danofloxacin
Jon A. Otero et al.
DRUG METABOLISM AND DISPOSITION (2013)
Potential Role of Epigenetic Mechanisms in the Regulation of Drug Metabolism and Transport
Magnus Ingelman-Sundberg et al.
DRUG METABOLISM AND DISPOSITION (2013)
Drug Transporters in Drug Efficacy and Toxicity
M. K. DeGorter et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
The Anthelmintic Triclabendazole and Its Metabolites Inhibit the Membrane Transporter ABCG2/BCRP
Borja Barrera et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Phenacetin Pharmacokinetics in CYP1A2-Deficient Beagle Dogs
Valerie J. Whiterock et al.
DRUG METABOLISM AND DISPOSITION (2012)
The impact of epigenomics on future drug design and new therapies
Christopher A. Hamm et al.
DRUG DISCOVERY TODAY (2011)
Polymorphism of cytochrome P450 A2 (CYP1A2) in pure and mixed breed dogs
M. C. Scherr et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2011)
Detection of the CYP1A2 1117C > T polymorphism in 14 dog breeds
J. S. Aretz et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2011)
Two novel SNPs of the ABCG2 gene and its associations with milk traits in Chinese Holsteins
Wangping Yue et al.
MOLECULAR BIOLOGY REPORTS (2011)
Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats
Christina J. Ramirez et al.
PHARMACOGENETICS AND GENOMICS (2011)
Breed distribution of the nt230(del4) MDR1 mutation in dogs
Irina Gramer et al.
VETERINARY JOURNAL (2011)
Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes
Katalin Jemnitz et al.
TOXICOLOGY IN VITRO (2010)
Biliary excretion of technetium-99m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1Δ mutation) and extrinsic (ketoconazole treated) P-glycoprotein deficiency
J. C. Coelho et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2009)
Combined use of ivermectin and triclabendazole in sheep: In vitro and in vivo characterisation of their pharmacological interaction
Adrian Lifschitz et al.
VETERINARY JOURNAL (2009)
P-glycoprotein contributes to the blood-brain, but not blood-cerebrospinal fluid, barrier in a spontaneous canine P-glycoprotein knockout model
Katrina L. Mealey et al.
DRUG METABOLISM AND DISPOSITION (2008)
Characterization of substrate specificity of dog CYP1A2 using CYP1A2-deficient and wild-type dog liver microsomes
Masashi Mise et al.
DRUG METABOLISM AND DISPOSITION (2008)
Implications of ABC transporters on the disposition of typical veterinary medicinal products
Jan A. Schrickx et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Breed distribution of the ABCB1-1Δ (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping
Katrina L. Mealey et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2008)
ABCB1-1Δ polymorphism can predict hematologic toxicity in dogs treated with vincristine
K. L. Mealey et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Pharmacogenomic importance of ABCG2
George Cusatis et al.
PHARMACOGENOMICS (2008)
Genetic support for a quantitative trait nucleotide in the ABCG2 gene affecting milk composition of dairy cattle
Hanne Gro Olsen et al.
BMC GENETICS (2007)
Ocular and systemic manifestations after oral administration of a high dose of enrofloxacin in cats
Marnie M. Ford et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2007)
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib
George Cusatis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Elucidation of the effects of the CYP1A2 deficiency polymorphism in the metabolism of 4-cyclohexyl-1-ethyl-7-methylpyrido[2,3-d] pyrimidine-2-(1H)-one (YM-64227), a phosphodiesterase type 4
Daisuke Tenmizu et al.
DRUG METABOLISM AND DISPOSITION (2006)
Genetic polymorphism of cytochrome P450s in beagles: possible influence of CYP1A2 deficiency on toxicological evaluations
H. Kamimura
ARCHIVES OF TOXICOLOGY (2006)
ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells
Tomoko Asashima et al.
PHARMACEUTICAL RESEARCH (2006)
The canine CYP1A2 deficiency polymorphism dramatically affects the pharmacokinetics of 4-cyclohexyl-1-ethyl-7-methylpyrido[2,3-d]pyrimidine-2-(1H)-one (YM-64227), a phosphodiesterase type 4 inhibitor
D Tenmizu et al.
DRUG METABOLISM AND DISPOSITION (2006)
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
R Kerb
CANCER LETTERS (2006)
Cytochrome P450 2E polymorphism in feline liver
N Tanaka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2005)
Canine mdr1 gene mutation in japan
A Kawabata et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2005)
Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a dogs living sample of herding breed in Australia
KL Mealey et al.
VETERINARY PARASITOLOGY (2005)
Cell culture models of the ocular barriers
M Hornof et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a novel benzodiazepine receptor partial inverse agonist in dogs
M Mise et al.
DRUG METABOLISM AND DISPOSITION (2004)
Identification of the novel canine CYP1A2 1117 C>T SNP causing protein deletion
D Tenmizu et al.
XENOBIOTICA (2004)
Breed distribution and history of canine mdr1-1Δ, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage
MW Neff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates
MJ Graham et al.
XENOBIOTICA (2003)
Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene
KL Mealey et al.
PHARMACOGENETICS (2001)
Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences
BLH Kraus et al.
XENOBIOTICA (2000)
分享论文
